Health Canada
- Status: approved
new thermo stable formulation of epoprostenol sodium (new thermo stable formulation of epoprostenol sodium) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.